Literature DB >> 33255952

The 25 kDa HCN Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity.

Julian Deppe1, Jasmin Weisemann1, Stefan Mahrhold1, Andreas Rummel1.   

Abstract

The extraordinarily potent clostridial neurotoxins (CNTs) comprise tetanus neurotoxin (TeNT) and the seven established botulinum neurotoxin serotypes (BoNT/A-G). They are composed of four structurally independent domains: the roles of the catalytically active light chain, the translocation domain HN, and the C-terminal receptor binding domain HCC are largely resolved, but that of the HCN domain sandwiched between HN and HCC has remained unclear. Here, mutants of BoNT/A, BoNT/B, and TeNT were generated by deleting their HCN domains or swapping HCN domains between each other. Both deletion and replacement of TeNT HCN domain by HCNA and HCNB reduced the biological activity similarly, by ~95%, whereas BoNT/A and B deletion mutants displayed >500-fold reduced activity in the mouse phrenic nerve hemidiaphragm assay. Swapping HCN domains between BoNT/A and B hardly impaired their biological activity, but substitution with HCNT did. Binding assays revealed that in the absence of HCN, not all receptor binding sites are equally well accessible. In conclusion, the presence of HCN is vital for CNTs to exert their neurotoxicity. Although structurally similar, the HCN domain of TeNT cannot equally substitute those of BoNT and vice versa, leaving the possibility that HCNT plays a different role in the intoxication mechanism of TeNT.

Entities:  

Keywords:  BoNT/A; BoNT/B; HCN domain; botulinum neurotoxin; gangliosides; synaptic vesicle protein; tetanus neurotoxin

Mesh:

Substances:

Year:  2020        PMID: 33255952      PMCID: PMC7760224          DOI: 10.3390/toxins12120743

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  62 in total

1.  Botulinum neurotoxin is shielded by NTNHA in an interlocked complex.

Authors:  Shenyan Gu; Sophie Rumpel; Jie Zhou; Jasmin Strotmeier; Hans Bigalke; Kay Perry; Charles B Shoemaker; Andreas Rummel; Rongsheng Jin
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

Review 2.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

3.  Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.

Authors:  Andreas Rummel; Timo Eichner; Tanja Weil; Tino Karnath; Aleksandrs Gutcaits; Stefan Mahrhold; Konrad Sandhoff; Richard L Proia; K Ravi Acharya; Hans Bigalke; Thomas Binz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

4.  Unique ganglioside recognition strategies for clostridial neurotoxins.

Authors:  Marc A Benson; Zhuji Fu; Jung-Ja P Kim; Michael R Baldwin
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

5.  The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.

Authors:  Andreas Rummel; Stefan Mahrhold; Hans Bigalke; Thomas Binz
Journal:  Mol Microbiol       Date:  2004-02       Impact factor: 3.501

6.  Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds.

Authors:  G Schiavo; A Santucci; B R Dasgupta; P P Mehta; J Jontes; F Benfenati; M C Wilson; C Montecucco
Journal:  FEBS Lett       Date:  1993-11-29       Impact factor: 4.124

7.  Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.

Authors:  Stefan Mahrhold; Tomas Bergström; Daniel Stern; Brigitte G Dorner; Crister Åstot; Andreas Rummel
Journal:  Biochem J       Date:  2016-06-16       Impact factor: 3.857

8.  Identification and characterization of a novel botulinum neurotoxin.

Authors:  Sicai Zhang; Geoffrey Masuyer; Jie Zhang; Yi Shen; Daniel Lundin; Linda Henriksson; Shin-Ichiro Miyashita; Markel Martínez-Carranza; Min Dong; Pål Stenmark
Journal:  Nat Commun       Date:  2017-08-03       Impact factor: 14.919

9.  Neuronal entry and high neurotoxicity of botulinum neurotoxin A require its N-terminal binding sub-domain.

Authors:  Jiafu Wang; Jianghui Meng; Marc Nugent; Minhong Tang; J Oliver Dolly
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

10.  Identification of a novel botulinum neurotoxin gene cluster in Enterococcus.

Authors:  Jason Brunt; Andrew T Carter; Sandra C Stringer; Michael W Peck
Journal:  FEBS Lett       Date:  2018-01-23       Impact factor: 4.124

View more
  2 in total

1.  Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in mice.

Authors:  Marco Pirazzini; Alessandro Grinzato; Davide Corti; Sonia Barbieri; Oneda Leka; Francesca Vallese; Marika Tonellato; Chiara Silacci-Fregni; Luca Piccoli; Eaazhisai Kandiah; Giampietro Schiavo; Giuseppe Zanotti; Antonio Lanzavecchia; Cesare Montecucco
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

Review 2.  Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.

Authors:  Marco Pirazzini; Cesare Montecucco; Ornella Rossetto
Journal:  Arch Toxicol       Date:  2022-03-25       Impact factor: 6.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.